Information Library
Results for: Case Studies - Data Management
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Energizing Enrollment
October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Competitive Edge - Ulcerative Colitis
February 2, 2011
Although faced with the challenge of recruiting for this small patient population, enrollment was completed two months ahead of schedule. -
Superior Teamwork - Renal Transplants
February 2, 2011
901 patients were randomized according to the protocol timelines. The database lock was achieved 11 days before the original target date. -
Bypassing Barriers - Refractory Partial Epilepsy
February 2, 2011
Despite a difficult and limited patient population, Quintiles randomized 388 patients (13 over target) 10 weeks ahead of schedule. -
H1N1 - Proactive Engagement
February 1, 2011
Despite short timelines and government requirements, an H1N1 vaccine study finished in time for the influenza season. -
Global Response HIV
February 1, 2011
Due to its global reach and extensive experience, Quintiles successfully managed 830 sites in 32 countries and recruited 14,521 patients. -
Acute Coronary Syndrome - Tailored Solutions
February 1, 2011
Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO. -
Data Transfer Express
October 13, 2010
An innovative solution to the challenging data transfer requirements of Eli Lilly. -
Global Data Solutions
September 15, 2010
Quintiles leveraged its unmatched experience and regional presence to open a free-standing, closed source data management center of excellence. -
Managing Trauma
September 14, 2010
Quintiles overcame the unpredictability of patient recruitment due to the emergency setup and the client was able to file for approval based on phase II data only.